Scynexis Switches Focus To Hospital Indications For Ibrexafungerp

 
• By Joseph Haas
Scynexis focus
Scynexis believes hospital-based indications will be more lucrative for its antifungal • Source: Shutterstock

More from Strategy

More from Business